Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis

Fig. 2

Meta-analysis of day 28 efficacy of artemisinin combination therapy administration (PR: DerSimonian-larid random-effects untransformed proportion).Abbreviations:- C.I.: confidence interval, n: events, N: total in the per-protocol analysis, DP: dihydroartemisinin-piperaquine, ASAQ: Artesunate–Amodiaquine, AL: Artemether–Lumefantrine, CDA: Chlorproguanil-dapsone-artesunate, AP: artesunate-pyronaridine, ASSMP: Artesunate-Sulphamethoxypyrazine-Pyrimethamine

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us